ArticleOncotarget2014

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer.

Christopher T Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.